Drug-Resistant Tuberculosis Types and Their Treatment Regimens Using First-Line, Second-Line Injectable, Third-Line, Fluoroquinolones, Aminoglycosides, Cyclic Polypeptides, Novel and Repurposed Anti-Tuberculosis Drugs
Crossref DOI link: https://doi.org/10.37871/jbres1542
Published Online: 2022-09
Update policy: https://doi.org/10.37871/jbres.policy
Mumena, David Kajoba
Kwenda, Geoffrey
Ngugi, Caroline Wangari
Nyerere, Andrew Kimanga